News
05-21-2010, 06:01 AM
Chronix Biomedical today reported a summary of data supporting the utility of its serum DNA blood tests for the early and accurate detection of breast cancer and prostate cancer. The unique testing algorithms developed by Chronix detected and correctly identified DNA fragments in the blood from dying (apoptotic) cancer cells with 92% sensitivity and 100% specificity in both prostate cancer and breast cancer.
More... (http://www.news-medical.net/news/20100521/Data-on-serum-DNA-blood-tests-for-early-detection-of-cancer-to-be-presented-at-ASCO-2010.aspx)
More... (http://www.news-medical.net/news/20100521/Data-on-serum-DNA-blood-tests-for-early-detection-of-cancer-to-be-presented-at-ASCO-2010.aspx)